NSE shareholding pattern
Aurobindo Pharma Limited shareholding pattern
As of the Jun 2026 shareholding pattern (quarter ended 2026-06-30), promoters held 51.88%, FIIs 16.38%, and DIIs 25.05% of Aurobindo Pharma Limited (AUROPHARMA). In the Mar 2026 pattern the same figures were promoter 51.82%, FII 15.24% and DII 25.82%. Promoter holding changed between the two filings, so the percentages moved for every category and the difference is not a count of shares bought or sold. The table below shows how promoter, FII, DII and public holding has moved quarter by quarter, taken from the NSE shareholding pattern.
Smart Money Report, Q2 FY27: shareholding patterns as they are filed, 1 Oct 2026 to 21 Oct 2026
Definition
A shareholding pattern is the quarterly breakdown of who owns a listed company, split across promoters, foreign institutional investors (FII), domestic institutional investors (DII), and the public. Indian companies file it every quarter under SEBI listing rules. Source: NSE shareholding pattern.
Aurobindo Pharma Limited shareholding by quarter
| Quarter | Promoter % | FII % | DII % | Public % | Filed |
|---|---|---|---|---|---|
| Jun 2026 | 51.88 | 16.38 | 25.05 | 6.69 | 2026-06-30 |
| Mar 2026 | 51.82 | 15.24 | 25.82 | 7.12 | 2026-03-31 |
| Dec 2025 | 51.82 | 13.95 | 27.66 | 6.57 | 2025-12-31 |
| Sep 2025 | 51.82 | 14.21 | 27.6 | 6.37 | 2025-09-30 |
| Jun 2025 | 51.82 | 14.38 | 26.93 | 6.87 | 2025-06-30 |
Disclosures shown are public regulatory filings. Data may be delayed or incomplete. Smart-money entities may no longer hold positions shown. Not investment advice.
Disclosure overlap on Aurobindo Pharma Limited
6 fund managers6 fund managers disclosed positions in Aurobindo Pharma Limited within the same window (Jul 11, 2026 – Oct 9, 2026), per AMFI mutual-fund portfolios. Who they are — and each underlying filing — is shown inside Flock.
A count of what was filed, per public regulatory filings. Not investment advice.
Related on Flock
- Smart money moves this filing week (insider trades, bulk deals and stake disclosures from the last 7 days)
- All NSE shareholding patterns (browse every company by name)
- What is a 13F filing? (how the US equivalent disclosure works)
- FII and DII activity, sourced and dated
- Today's NSE and BSE bulk and block deals
- Shareholding patterns for other companies in the same industry: Bajaj Healthcare Limited, Biocon Limited, Blue Jet Healthcare Ltd, Caplin Point Laboratories Ltd, Cipla Limited, Cohance Lifesciences Limited, Concord Biotech Limited, Corona Remedies Limtied
- When smart money's filings overlap (multi-entity disclosure overlap, explained)
Frequently asked questions
What is the promoter holding in Aurobindo Pharma Limited?
As of the Jun 2026 shareholding pattern, promoters held 51.88% of Aurobindo Pharma Limited (AUROPHARMA). Figures are taken from the NSE shareholding pattern filing dated 2026-06-30 and may change each quarter. Not investment advice.
What is the FII holding in Aurobindo Pharma Limited?
Foreign institutional investors held 16.38% of Aurobindo Pharma Limited as of the Jun 2026 pattern, versus 15.24% in the Mar 2026 pattern. Promoter holding changed between the two filings, so both are levels rather than a change in holding. Source: NSE shareholding pattern, quarter ended 2026-06-30. Not investment advice.
How often is the shareholding pattern updated?
Listed Indian companies disclose their shareholding pattern every quarter under SEBI's listing rules. Flock re-stamps each page when a new quarterly pattern is filed, so the freshness chip reflects the true age of the latest data.
The Smart Money Digest
A free weekly email of notable disclosure activity — every line with its filing date and source link. No advice, just filings. Unsubscribe anytime.